Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Methylprednisolone Hemisuccinate × 30 days × Clear all

Sponsor

Conditions

Hematologic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 24 apalutamide 22 Specimen Handling 19 Abiraterone Acetate 18 enzalutamide 17 Pluvicto 16 Prednisone 15 Radiosurgery 12 Androgen Antagonists 12 Docetaxel 10 darolutamide 9 Leuprolide 8 Biopsy 7 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 7 relugolix 6 Triptorelin Pamoate 6 Surveys and Questionnaires 6 Radiotherapy 6 Nivolumab 6 cabazitaxel 5 bicalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 abiraterone 5 Standard of Care 5 Radiation 5 Goserelin 5 Educational Status 5 Carboplatin 5 olaparib 4 gallium 68 PSMA-11 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡